Viewing Protocol Section

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
Viewing Protocol Section

Thank You for evaluating our software.

Clinical Trials

To give you an idea of how we make custom software. We have taken all of the Clinical Trials Information from our Federal Government(https://clinicaltrials.gov/).

The JSON File Structure of the files is as follows: Full Study -> Study => Sections => Modules. You are currently viewing a Protocol Section and its Modules.

We give the table structure here to give you an idea of what you are looking at. We put the explanation to the left and the data to the right.

A Protocol Section has the following Modules.

1. Identification Module

2. Status Module

3. Sponsor Collaborators Module

4. Oversight Module

5. Description Module

6. Conditions Module

7. Design Module

8. Arms Interventions Module

9. Outcomes Module

10. Eligibility Module

11. Contacts Locations Module

12. References Module

13. IPD Sharing Statement Module

Viewing Protocol Section

Study NCT06481709
Ignite Creation Date: 2024-07-17 @ 11:36 AM
Last Modification Date: 2024-10-26 @ 3:33 PM
Study NCT ID: NCT06481709
Protocol Section: NCT06481709
Start Identification Module Data
Expand Identification Module Data
Brief Title: Study on Sapropterin Dihydrochloride Oral Suspension in Healthy Subjects
Official Title: A Pilot Phase 1 Randomized Open-Label Single-Dose Four-Way Crossover Study to Compare the Pharmacokinetics of Sapropterin Dihydrochloride 100 mgmL Oral Suspension Product Code RLF-OD032 Test With Kuvan Sapropterin Dihydrochloride 100 mg Powder for Oral Solution Reference and to Evaluate the Effect of Food and the Effect of Water on the Bioavailability of Sapropterin Dihydrochloride 100 mgmL Oral Suspension in Healthy Subjects
Acronym: None
Organization: APR Applied Pharma Research sa
Organization Class: OTHER
Organization Study ID: 2023-5439
Start Status Module Data
Status Verified Date: 2023-11
Overall Status: RECRUITING
Study First Submit Date:
Study First Submit QC Date:
Last Update Submit Date:
Status:
Start Sponsor Collaborators Module Data
Investigator:
Lead Sponsor: APR Applied Pharma Research sa
Lead Sponsor Class: OTHER
Lead Sponsor: APR Applied Pharma Research sa
Start Oversight Module Data
Description Module:
Study Last Update Post Date Type(Status Module):
Attachment: Upload